Table 2 Laboratory data on admission and treatments during hospitalization.
Laboratory data on admission | |||||
WBC count (/μL) | 6040 (4325–8115) | 5360 (3720–7080) | 5750 (3925–7965) | 7600 (6050–11,060) | < 0.0001* |
Neutrophil count (/μL) | 4603 (2852–6331) | 3692 (2422–5411) | 4070 (2604–5789) | 6445 (4956–9665) | < 0.0001* |
Lymphocyte count (/μL) | 834 (579–1109) | 1026 (789–1527) | 788 (623–934) | 612 (270–809) | < 0.0001* |
Platelet count (× 1000/μL) | 188 (142–243) | 193 (151–247) | 165 (123–217) | 208 (152–270) | 0.048* |
Hemoglobin (g/dL) | 13.6 (12.0–15.0) | 14 (13.2–15.4) | 13.6 (11.5–17.8) | 13.1 (11.7–14.8) | 0.050* |
D-dimer (μg/mL) | 1.2 (1.0–1.6) | 1.06 (0.86–1.41) | 1.27 (1.04–2.06) | 1.24 (1.15–1.47) | 0.014* |
CRP (mg/dL) | 4.1 (0.9–9.3) | 1.3 (0.3–4.5) | 5.6 (1.7–10.8) | 8.7 (4.2–15.4) | < 0.0001* |
Total bilirubin (mg/dL) | 0.5 (0.4–0.8) | 0.5 (0.3–0.8) | 0.7 (0.4–0.8) | 0.5 (0.4–0.7) | 0.305 |
Creatinine (mg/dL) | 0.82 (0.64–1.17) | 0.78 (0.61–0.91) | 0.94 (0.63–1.50) | 0.82 (0.68–1.70) | 0.141 |
Received treatment (percent [number]) | |||||
Mechanical ventilation use | 28.7 [39] | 0.0 [0] | 6.8 [3] | 97.3 [36] | < 0.0001* |
High-FLOW Nasal Oxygenation use | 0.7 [1] | 0.0 [0] | 0.0 [0] | 2.7 [1] | 0.270 |
Systemic steroids | 58.1 [79] | 27.3 [15] | 72.7 [32] | 86.5 [32] | < 0.0001* |
Ciclesonide | 56.6 [77] | 52.7 [29] | 50.0 [22] | 70.3 [26] | 0.140 |
Remdesivir | 34.6 [47] | 3.6 [2] | 43.2 [19] | 70.3 [26] | < 0.0001* |
Favipiravir | 27.2 [37] | 7.3 [4] | 36.4 [16] | 45.9 [17] | < 0.0001* |
Tocilizumab | 5.9 [8] | 0.0 [0] | 0.0 [0] | 21.6 [8] | < 0.0001* |
Chlorquine | 12.5 [17] | 16.4 [9] | 6.8 [3] | 13.5 [5] | 0.353 |
